Tel Aviv University researchers have discovered a significant link between behavioral stress and the effectiveness of vaccines. Acute stress, they found, can both enhance and impair the body’s immune response to vaccination.
Multiple organ inflammation is a hallmark of systemic autoimmune disorders, which can have disastrous effects on patients. Treatments for these disorders are desperately needed. In some clinical trials, RNase therapies appear promising, but not in all. The causes of this variability have bee
A group of researchers is looking into natural killer (NK) cells as an alternative treatment for neuropathic pain in the midst of a global opioid epidemic.
In recent research, researchers from the National Institutes of Health (NIH) found that infants with mitochondrial abnormalities had altered B cell activity, which led to a weaker and less diverse antibody response to viral infections. The study, published in Frontiers in Immunology, was
Researchers have discovered how anti-viral cytokines can reduce the immune response to tuberculosis. The findings were published in the journal 'Cellular Immunology.'
Researchers from the National Institutes of Health (NIH) discovered in a recent study that infants with mitochondrial abnormalities had altered B cell function, which resulted in a weaker and less varied antibody response to viral infections. Researchers at the National Human Genome Research
Researchers have discovered how anti-viral cytokines can reduce the immunological response to tuberculosis. The study was published in the journal, 'Cellular Immunology.'
Immunotherapy is a relatively new and successful cancer treatment. It causes the immune system to identify tumours as invaders and attack them. Immunotherapy, however, does not benefit all patients. Why? Scientists aren't always certain.
Sometimes, immunotherapy patients experience side eff
Immunotherapy is one of the most recent and effective cancer treatments. It causes the immune system to identify tumours as intruders in the body and attack them. However, not all patients benefit from immunotherapy. Why? Scientists are not always sure.
A method that malignant tumours use to remotely prevent the emergence of an immune response that would halt their growth has been discovered by researchers at Baylor College of Medicine and associated institutions.
Children with recurrent brain tumours tolerated the first in-human trial of a novel immunotherapy well, and many were able to experience unexpected months of a more normal life, according to researchers. Immunotherapy disables a natural enzyme that tumours hijack for their defence.
ccording to Okinawa Institute of Science and Technology researchers, gut bacteria that break down a sugar called fucose may be suppressing our immune response to the COVID-19 mRNA vaccine (OIST).